Camlin Fine Sciences Board to Consider Q2 Results and Rights Issue
Camlin Fine Sciences Ltd 路 Intimation 路 03 Nov 2026, 5:30 am
Camlin Fine Sciences Board to Consider Q2 Results and Rights Issue Camlin Fine Sciences has scheduled its Board of Directors meeting for 3rd Nov'26 to evaluate and approve the unaudited standalone and consolidated financial results for the quarter and half-year ended 30th Sep'26. Additionally, the board will consider a fundraising proposal via a rights issue of equity shares or other securities, subject to regulatory approvals. The company's trading window remains closed for designated persons from 1st Oct'26 through 5th Nov'26.
Original exchange filing (PDF)
More announcements from Camlin Fine Sciences Ltd
- The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on November .... 路 13 Nov 2026
- The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on November 13, 2026 for Ashish Subhash Dandekar 路 13 Nov 2026
- The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on November .... 路 09 Nov 2026
- The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on November 09, 2026 for Ashish Subhash Dandekar 路 09 Nov 2026
- Earnings call Transcript - Q2 & H1FY27 路 06 Nov 2026
- Audio Recording of the Investor Call - Q2 & H1FY27 路 04 Nov 2026
- Investor Presentation - Q2 & H1FY27 路 03 Nov 2026
- Camlin Fine Sciences Limited has informed the Exchange regarding Outcome of Board Meeting for raising of fund by way of issue of equity shares held on November 03, 2026. 路 03 Nov 2026
